Emily Woodworth - 12 Feb 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Global Controller and CAO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
12 Feb 2026
Net transactions value
-$17,937
Form type
4
Filing time
17 Feb 2026, 19:07:55 UTC
Previous filing
05 Mar 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Woodworth Emily SVP, Global Controller and CAO 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH /s/ Susan Thompson, Attorney-in-Fact 17 Feb 2026 0002013518

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +481 +68% $0.000000 1,193 12 Feb 2026 Direct F1, F2
transaction BSX Common Stock Tax liability $17,937 -242 -20% $74.12 951 12 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -481 -33% $0.000000 962 12 Feb 2026 Common Stock 481 Direct F1, F3
transaction BSX Restricted Stock Units Award $0 +6,071 $0.000000 6,071 12 Feb 2026 Common Stock 6,071 Direct F1, F4
transaction BSX Stock Option (Right to Buy) Award $0 +5,584 $0.000000 5,584 12 Feb 2026 Common Stock 5,584 $74.12 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Includes shares acquired on June 30, 2025 under the Company's Employee Stock Purchase Plan based upon the most current data available.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.
F5 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.